Drug class in one race
Dopamine D2/D3 receptor + 5-HT7 receptor drugs for Schizophrenia
2 tracked Dopamine D2/D3 receptor + 5-HT7 receptor drugs in the Schizophrenia race. The class explanation lives on the Dopamine D2/D3 receptor + 5-HT7 receptor page; the full indication pipeline across every mechanism is on the Schizophrenia page.
1 approved / phase 41 Phase 3
Head-to-head evidence: LB-102 (methylated amisulpride) vs Lurasidone